Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations.
1995
Intratumor microvessel density as a prognostic factor in cancer.
1995
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
2000
Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/ protein and vascular endothelial growth factor
2002
Untangling the ErbB signalling network
2001 Standout
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
2003
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
2002
The relationship between prognostic and predictive factors in the management of breast cancer
1998
Hypoxia — a key regulatory factor in tumour growth
2002 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Differences in Risk Factors for Local and Distant Recurrence After Breast-Conserving Therapy or Mastectomy for Stage I and II Breast Cancer: Pooled Results of Two Large European Randomized Trials
2001
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas
2005 StandoutNobel
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
1996
Breast cancer
2016 Standout
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
1999 StandoutNature
Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement
2016
Oncogenic kinase signalling
2001 StandoutNature
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Recurrence Rates after Treatment of Breast Cancer with Standard Radiotherapy with or without Additional Radiation
2001 Standout
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.
1997
Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis
1999
Angiogenesis and metastasis
1996
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
2001 Standout
Scleroderma
2009 Standout
Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study
1997
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.
1997
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
1995
Photodynamic therapy of malignant glioma
1991
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
The microenvironment of the tumour–host interface
2001 StandoutNature
Review: The Integrin αvβ3: Angiogenesis and Apoptosis
1995
Clinical Applications of Research on Angiogenesis
1995 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma.
1998
Hyperthermia, Radiation and Chemotherapy: The Role of Heat in Multidisciplinary Cancer Care
2014
The role of angiogenic growth factors in breast cancer progression
1996
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Hyperplasia of dermal microvascular pericytes in scleroderma*
2004
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
1996 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis
1998
Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
1997
Neuroblastoma
2007 Standout
Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen
1995
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Mechanisms of angiogenesis and arteriogenesis
2000 Standout
Disseminated Intravascular Coagulation
1999 Standout
Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
2007
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
2002 StandoutNobel
In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
1996
Prognostic significance of ERRB3 overexpression in oral squamous cell carcinoma
1995
Tumorigenesis and the angiogenic switch
2003 Standout
Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas
1996
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment
2000
Immunohistochemical analysis of integrin αvβ3 expression on tumor‐associated vessels of human carcinomas
1997
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma.
2001
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Liposomal Formulations in Clinical Use: An Updated Review
2017 Standout
Type 1 growth factor receptors: an overview of recent developments
1995
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Tumour vasculature as a target for anticancer therapy
2000
Breast Cancer Treatment
2019 Standout
Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer.
1999
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Regulation of Mammalian O2Homeostasis by Hypoxia-Inducible Factor 1
1999 StandoutNobel
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Reduction of wound angiogenesis in patients treated with BMS-275291, a broad spectrum matrix metalloproteinase inhibitor.
2003
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Angiogenesis and Tumor Metastasis
1998
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
1998
Microvessel Density as a Prognostic Factor in Women with Breast Cancer
2004
Works of Sergio Maluta being referenced
c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma—an immunocytochemical study
1994
Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.
1994
Intratumoral microvessel density and L53 protein: Correlation with metastasis in head‐and‐neck squamous‐cell carcinoma
1993
Intraoperative Electron Radiotherapy (IOERT) as an Alternative to Standard Whole Breast Irradiation: Only for Low-Risk Subgroups?
2014
Conformal radiotherapy plus local hyperthermia in patients affected by locally advanced high risk prostate cancer: Preliminary results of a prospective phase II study
2007
The role of hyperthermia in the battle against cancer.
2011
The role of hyperthermia in the battle against cancer
2010
TREATMENT OF LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH CONCURRENT RADIOCHEMOTHERAPY - RANDOMIZED COMPARISON OF CISPLATIN VERSUS CARBOPLATIN
1993
RECURRING GYNAECOLOGIC CANCER TREATED WITH PHOTODYNAMIC THERAPY
1987